Medicines with strongly enhanced in vivo stability, optimal receptor interaction, and early indication of clinical success.This project addresses the large market opportunity for an innovative therapeutic peptide stabilization platform technology and adds further value by early selection for high chance for clinical success via a real-time, label-free, complete pathway activation picture in human cells. (bron: Eurostars website, projecten database)(bron: www.eurekanetwork.org/project-search)
